← Back to Search

Behavioral Intervention

Physical Activity for Heart Disease and Obesity Prevention (AFL Trial)

N/A
Waitlist Available
Led By Noe C Crespo, MS, MPH, PhD
Research Sponsored by Noe Crespo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children aged 6-11 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to help Latino families in San Diego, California and Mexicali, Baja California improve their fitness and physical activity levels. Both cities have high rates of heart disease and obesity, so

Who is the study for?
This trial is for underserved Latino families living near the U.S.-Mexico border, specifically in San Diego and Mexicali. It aims to help those at risk of heart disease and obesity by encouraging physical activity. Families interested in participating must be willing to engage with community center programs.
What is being tested?
The intervention being tested is a program designed to promote physical activity among Latino families. The study will work through local community centers, aiming to improve fitness levels and reduce the risk of cardiovascular diseases and obesity.
What are the potential side effects?
Since this trial involves physical activity as an intervention, potential side effects may include muscle soreness, fatigue, or minor injuries related to exercise. However, these are typically mild and can often be managed with proper guidance.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 6 and 11 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child Physical Activity (PA)
Secondary study objectives
Implementation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ProgramExperimental Treatment1 Intervention
The 12-month intervention will progressively increase in intensity \& complexity to teach parents/children more complex sports skills \& behavioral techniques, \& to prepare them to become future team leaders for nutrition education and sports sessions. In addition, the family Olympics events will take place after every 3-month to reinforce progression, social support, \& progressive improvements: Phase 1: Beginner (months 0-3) will focus on introductory concepts \& basic sports skills \& will focus on establishing consistent behavioral patterns \& social support. Phase 2: Intermediate (months 4-6) will begin to introduce slightly more complex nutrition \& behavioral concepts, increase difficulty of sport skills, \& reinforce behavioral patterns from phase 1. Phase 4: Advanced (months 10-12) will teach parents \& children advanced sports skills \& nutrition knowledge so that they may become team leaders to help implement future activity sessions and nutrition education sessions.
Group II: Control GroupActive Control1 Intervention
Centers that are randomly assigned to the control group will continue with regularly schedule programing and activities. Families recruited from control centers will be allowed to take part in all the programs offered at the recreation centers, with exception to the AFL program since it will not be offered at those centers. Control group families will also receive publicly available information regarding the benefits of PA and strategies to become physically active (e.g., CDC PA guidelines websites \& handbook). 12-month sustainability phase will involve assessments at the organizational and individual levels. At the organizational level, we will examine the number of AFL sessions held at each recreation center and document the number of phone consultations, length of calls, and barriers addressed. At the individual level, we will examine the number of minutes of adult and child habitual PA.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Activity
2019
Completed Phase 3
~4760

Find a Location

Who is running the clinical trial?

Noe CrespoLead Sponsor
San Diego State UniversityOTHER
169 Previous Clinical Trials
114,584 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
434 Previous Clinical Trials
1,378,543 Total Patients Enrolled
~193 spots leftby Mar 2027